论文信息 - Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter Phase 2 Trial. - 字舞流文

Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter Phase 2 Trial.

Y. Hosomi | S. Miyamoto | N. Kikuchi | K. Azuma | Hiroshi Tanaka | H. Kunitoh | Kazuhiko Yamada | H. Okamoto | H. Itani | A. Hamada | A. Bessho | N. Fukamatsu | S. Hosokawa | Y. Nakahara | H. Ishii | M. Ishii | K. Kusaka | H. Aono | Y. Mori